Latest Liquidity News

MRG Metals Limited has seen its MRQOD securities suspended from ASX trading pending regulatory compliance, raising questions about the company’s next steps.

Strickland Metals has completed the distribution of Gateway Mining shares to its shareholders following the sale of its Yandal Project, marking a significant step in its corporate restructuring.

Love Group Global Ltd plans a shareholder vote on returning 3 cents per share, signalling confidence in its cash position and growth outlook.

Cullen Resources has agreed to sell its Wyloo iron ore royalty to Vox Royalty for A$1.5 million cash, while retaining a significant payment right tied to mining commencement.

Regal Partners reports a 48% drop in statutory profit for H1 2025 despite growing funds under management to $17.7 billion, while strategically expanding into hotel real estate with the Mayfair Hotel acquisition.

Santos Limited reported robust first-half 2025 results, underpinned by strong cash flow and disciplined cost management, while accelerating the start-up of its Pikka phase 1 project to early 2026. The company declared a higher interim dividend, reflecting confidence in its growth trajectory.

Genetic Signatures reported a 63% revenue increase to $15.9 million in FY25, alongside a 28% reduction in underlying losses and a strategic shift in its automated diagnostics platform development.

GDI Property Group reports robust leasing activity with over 32,000sqm leased in FY25, fueling a 20% increase in Funds From Operations. Strategic asset sales and refinancing position the company well for continued growth in a tightening Perth office market.

GDI has reported a strong FY25 with a 22% increase in Property Funds From Operations, robust leasing activity, and significant asset sales, while maintaining its distribution guidance for FY26.

GDI Property Group has reported a strong turnaround in FY25, posting a $35.6 million net profit and a 20% increase in Funds From Operations, while maintaining its distribution at 5 cents per security.

Genetic Signatures Limited reported a 63% revenue surge to $15.9 million in FY25, driven by strong Australian sales and progress in EMEA, while navigating a $20.1 million net loss and a strategic pivot towards partnerships for automated diagnostics.

EVT Limited reported a solid financial year with normalised revenue rising 1.3% to A$1.237 billion and EBITDA up 6.3%, while net profit after tax surged 593%, driven by operational resilience and strategic growth initiatives including a major hotel management acquisition.